RecruitingNot Applicable

Inappropriate Sinus Tachycardia Registry

United States500 participantsStarted 2022-03-01

Plain-language summary

The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.
✓. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements

Exclusion criteria

✕. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS.
✕. Subject with exclusion criteria required by FDA or local governance

What they're measuring

AtriCure commercially available devices used to treat IST or POTS

Timeframe: 12 months

Trial details

NCT IDNCT05107635

SponsorAtriCure, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-01

Contact for this trial

Registry Specialist

866-349-2342 IST-Registry@atricure.com

View on ClinicalTrials.gov More Inappropriate Sinus Tachycardia trials